Navigation Links
Halting immune response could save brain cells after stroke

MADISON A new study in animals shows that using a compound to block the body's immune response greatly reduces disability after a stroke.

The study by scientists from the University of Wisconsin School of Medicine and Public Health also showed that particular immune cells CD4+ T-cells produce a mediator, called interleukin (IL) -21 that can cause further damage in stroke tissue. Moreover, normal mice, ordinarily killed or disabled by an ischemic stroke, were given a shot of a compound that blocks the action of IL-21. Brain scans and brain sections showed that the treated mice suffered little or no stroke damage.

"This is very exciting because we haven't had a new drug for stroke in decades, and this suggests a target for such a drug," says lead author Dr. Zsuzsanna Fabry, professor of pathology and laboratory medicine.

Stroke is the fourth-leading killer in the world and an important cause of permanent disability. In an ischemic stroke, a clot blocks the flow of oxygen-rich blood to the brain. But Fabry explains that much of the damage to brain cells occurs after the clot is removed or dissolved by medicine. Blood rushes back into the brain tissue, bringing with it immune cells called T-cells, which flock to the source of an injury.

The study shows that after a stroke, the injured brain cells provoke the CD4+ T-cells to produce a substance, IL-21, that kills the neurons in the blood-deprived tissue of the brain. The study gave new insight how stroke induces neural injury.

Fabry's co-author Dr. Matyas Sandor, professor of pathology and laboratory medicine, says that the final part of the study looked at brain tissue from people who had died following ischemic strokes. It found that CD4+ T-cells and their protein, IL-21 are in high concentration in areas of the brain damaged by the stroke.

Sandor says the similarity suggests that the protein that blocks IL-21 could become a treatment for stroke, and would likely be administered at the same time as the current blood-clot dissolving drugs.

"We don't have proof that it will work in humans," he says, "but similar accumulation of IL-21 producing cells suggests that it might."

Graduate student Benjamin S. D. Clarkson and scientist Changying Ling were key members of the UW research team, as was Dr. Dandan Sun, formerly of the UW neurosurgery department and now at the University of Pittsburgh, and Dr. Vijay Kuchroo, of the Harvard Medical School.

The paper was published this week in the Journal of Experimental Medicine. A link is available here:


Contact: Susan Lampert Smith
University of Wisconsin-Madison

Related medicine news :

1. ACP, others oppose paying for fiscal cliff by halting Medicaid primary care fee increases
2. MD Anderson, MedImmune join forces to advance cancer immunotherapy
3. Cancer vaccine could use immune system to fight tumors
4. Vitamin A may help boost immune system to fight tuberculosis
5. Immune cells need a second opinion
6. Benaroya Research Institute receives 7-year award to lead Immune Tolerance Network
7. FASEB announces 2014 Science Research Conference: Biology of the Immune System
8. Voices Against Brain Cancer Comments On How Boosting One’s Immune System Can Help Fight Tumor Growth
9. Platinum Soursop: The Natural Health Supplement Helps to Improve Cells Functions & Supports Immune System Now with 1 Extra Bottle Offer
10. Does the bodys immune response to viral vector delivery systems affect the safety or efficacy of gene therapy?
11. Platinum Soursop-The natural health supplement to improve immune system and enhance Mood is finally available for purchase
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
Breaking Medicine Technology: